Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Neurizon Leadership Roundtable Webinar Reminder and Updated Investor Presentation Highlights: ? Shareholders and interested investors are...
Updated Investor Presentation and Webinar Reminder
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
In the deck
Earlier from Neurizon Therapeutics
- FDA Type C Feedback, HEALEY trial potentially registrational
- Dr Chris Bremer commences as Neurizon CEO
- Change of Director's Interest Notice
- Notification of cessation of securities - NUZ
- Neurizon Announces Partial Redemption of Convertible Notes
Later from Neurizon Therapeutics
- Change of AGM Date
- Notice of Annual General Meeting/Proxy Form
- Appendix 4C & Quarterly Update
- Trading Halt
- Firm commitments to raise A$4.3m and announcement of SPP
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics